Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients. [PDF]
Krasniqi X +4 more
europepmc +1 more source
The "No-Reflow" Phenomenon Far Beyond the Cath Lab. [PDF]
Pozetti AH, Ribeiro HB.
europepmc +1 more source
Intracoronary adrenaline for the treatment of refractory no-reflow phenomenon: A single-centre experience. [PDF]
Desperak P +5 more
europepmc +1 more source
Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: rationale and design of the EMPA-PCI trial. [PDF]
Solis-Jimenez F +14 more
europepmc +1 more source
Neutrophil Percentage/Albumin Ratio as an Independent Predictor of the No-Reflow Phenomenon in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. [PDF]
Yavcin O, Yilmaz Y.
europepmc +1 more source
Reduced adenosine receptor expression in ACS patients with no-reflow phenomenon undergoing primary PCI. [PDF]
Bagheri A +4 more
europepmc +1 more source
Noninvasive Evaluation of No-Reflow Phenomenon [PDF]
openaire +1 more source
Predictive value of the Naples prognostic score for no-reflow phenomenon after saphenous vein graft stenting. [PDF]
Yılmaz C +6 more
europepmc +1 more source
Pathological roles of mitochondrial dysfunction in endothelial cells during the cerebral no-reflow phenomenon: A review. [PDF]
Luo X, Zhang S, Wang L, Li J.
europepmc +1 more source
The effect of the systemic immune-inflammatory index on the no-reflow phenomenon in patients undergoing saphenous vein intervention. [PDF]
Cakmak AC +5 more
europepmc +1 more source

